"The Big Bang Theory" concluded its 12-season run with several of its central characters settled into marriages and family life, while Raj (Kunal Nayyar) remained single when the series came to an end ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

At a time when Indian families are changing conversations around modern parenting, a new show has arrived on OTT, which focuses on a single father at the center of the story. After giving multiple ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...

Kolkata (West Bengal) [India], October 31 (ANI): All India Trinamool Congress (AITC) announced that it would set up Anchal (area) wise help desks from November 4 till December 4 in the wake of the ...

Trinamool Congress (TMC) leader Kunal Ghosh on Friday accused Union Home Minister Amit Shah and Bharatiya Janata Party (BJP) of "politically pressuring" the Election Commission (EC) over the ongoing ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

Recursion Pharmaceuticals, Inc. leverages AI to accelerate drug discovery, offering both a licensing platform and an internal drug development pipeline. RXRX faces heavy competition, ongoing operating ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...